开发用于治疗类风湿性关节炎的新一代肿瘤坏死因子α拮抗剂。 - Suppr

Developing a new generation of TNFalpha antagonists for the treatment of rheumatoid arthritis.

作者信息

Fleischmann Roy, Shealy Dave

机构信息

University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Mol Interv. 2003 Sep;3(6):310-8. doi: 10.1124/mi.3.6.310.

DOI:10.1124/mi.3.6.310

PMID:14993463

Abstract

摘要

相似文献

Developing a new generation of TNFalpha antagonists for the treatment of rheumatoid arthritis.

Mol Interv. 2003 Sep;3(6):310-8. doi: 10.1124/mi.3.6.310.

TNFalpha therapy in psoriatic arthritis and psoriasis.

Ann Rheum Dis. 2004 Jul;63(7):755-8. doi: 10.1136/ard.2004.020719.

Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.

Dermatol Ther. 2009 Jan-Feb;22(1):61-73. doi: 10.1111/j.1529-8019.2008.01217.x.

Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.

Dermatol Online J. 2008 Sep 15;14(9):12.

Tumor necrosis factor-alpha blockade and the risk of vasculitis.

J Rheumatol. 2004 Oct;31(10):1885-7.

Mechanisms of action of tumor necrosis factor antagonist and granulomatous infections.

J Rheumatol. 2004 Oct;31(10):1888-92.

[Up-date on the use of infliximab in dermatology. Introduction].

Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:1.

[Tumor necrosis factor modulators in the treatment of rheumatoid arthritis].

Duodecim. 1999;115(18):1969-76.

Emerging biologic drugs for the treatment of rheumatoid arthritis.

Autoimmun Rev. 2005 Nov;4(8):537-41. doi: 10.1016/j.autrev.2005.04.016.

TRU-015, a fusion protein derived from an anti-CD20 antibody, for the treatment of rheumatoid arthritis.

Curr Opin Mol Ther. 2010 Feb;12(1):115-23.

引用本文的文献

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?

Patient Prefer Adherence. 2016 Feb 5;10:123-34. doi: 10.2147/PPA.S94396. eCollection 2016.

Drug therapies in dermatology.

Clin Med (Lond). 2014 Feb;14(1):47-53. doi: 10.7861/clinmedicine.14-1-47.

The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what's in it for African and Middle Eastern rheumatologists.

Clin Rheumatol. 2012 Sep;31(9):1281-7. doi: 10.1007/s10067-012-2040-2. Epub 2012 Aug 9.

Certolizumab pegol.

MAbs. 2010 Mar-Apr;2(2):137-47. doi: 10.4161/mabs.2.2.11271.

Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis.

Rheumatol Int. 2006 Mar;26(5):473-80. doi: 10.1007/s00296-005-0085-0. Epub 2005 Dec 9.

Treatment of Autoimmune Hepatitis: Current and Future Therapies.

Curr Treat Options Gastroenterol. 2004 Oct;7(5):413-420. doi: 10.1007/s11938-004-0054-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Developing a new generation of TNFalpha antagonists for the treatment of rheumatoid arthritis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献